1.Quality Standard of Chenxiang Shuwei Powder
China Pharmacy 2005;0(15):-
OBJECTIVE: To establish the quality standard of Chenxiang shuwei poweder. METHODS: The qualitative analysis of Rhubarb in Chenxiang shuwei powder was carried out using TLC and the quantitative analysis of Hesperidin was carried out using RP-HPLC on a column of Luna C18(2)(150 mm?4.6 mm,5 ?m). The mobile phase consisted of methyl alcohol-acetic acid-aquifer(35∶4∶61) with a flow rate of 1.0 mL?min-1 at a detection wavelength of 283 nm. RESULTS: The TLC spots of Chenxiang shuwei powder were clear with good resolution. The linear range of Hesperidin was 0.12~2.40 ?g (r=0.999 9). The average recovery was 98.0%(RSD=0.9%,n=9).CONCLUSION: The established standard is applicable for the quality control of Chenxiang shuwei powder.
2.Comparison of Two Kinds of Packing Container for Hospital- prepared Infusion Fluid
Yihui ZHENG ; Zeqing ZHOU ; Mianguang WANG
China Pharmacy 2001;12(3):177-178
OBJECTIVE:To probe the advantages and disadvantges of soft packing container of hospital- prepared infusion fluid.METHODS:The hospital- prepared bottled infusion fluid was compared with soft parking fluid in respect to production costs,quality of preparation and clinical use.RESULTS & CONCLUSION:The soft packing infusion fluid has developing potential,however,at present there exist some problems to be settled.It can not take the place of bottled infusion fluid in the near future.
3.Identification of Bismuth Subcarbonte in Weishusan
Yihui ZHENG ; Zeqing ZHOU ; Li LI
China Pharmacy 2001;0(10):-
OBJECTIVE:To establish the chemical identification method of bis muth subcarbonte in weishusan.METH?ODS:The samples were ignited,then bismuth subcarbonate in residue was identified by the identification method of bismuth of identification method of potassium iodide from Chinese Pharmacopenia,with dilute nitric acid as solvent.RESULTS:Bis?muthic salt positive result was found in all dilute nitric acid solvent,this method could eliminate the interference with identi?fication of bismuth subcarbonate from traditional Chinese medicinal components in weishusan,it could also exclude the pseu?do-positive and pseudo-negative reaction,the color was easy to identify.CONCLUSION:This method is simple and stable and therefore applicable to quality control of weishusan.
4.Comparison of Two Kinds of Packing Container for Hospital-prepared Infusion Fluid
Yihui ZHENG ; Zeqing ZHOU ; Mianguang WANG
China Pharmacy 1991;0(03):-
OBJECTIVE:To probe the advantages and disadvantges of soft packing container of hospital-prepared infusion fluid.METHODS:The hospital-prepared bottled infusion fluid was compared with soft parking fluid in respect to production costs,quality of preparation and clinical use.RESULTS & CONCLUSION:The soft packing infusion fluid has developing potential,however,at present there exist some problems to be settled.It can not take the place of bottled infusion fluid in the near future.
5.Correction and Rank Sun Test for Standard of Bismuth Subcarbonate Content in Quality Control of Weishusan
Yihui ZHENG ; Yuyun ZHANG ; Zeqing ZHOU ; Zongmao ZHENG
China Pharmacy 1991;0(06):-
OBJECTIVE:To correct the standard of bismuth content in Weishusan.METHODS:The contents of effective bismuth in Weishusan and other three reference substances were detected by compleximetry.After adjusting the dosage of Weishusan,clinical rank sum test was carried out.RESULTS:The content of bismuth in original formula of Weishusan was rather high,therefore the inventory of bismuth subcarbonate in preparation technic of Weishusan should be reduced to7.0kg.CONCLUSION:The quality standard should be reformulated as bismuth subcarbonate0.1g(?10%)in per gram of Weishusan.
6.Determination of Bismuth Subcarbonate in Weishu Powder
Zeqing ZHOU ; Yihui ZHENG ; Hongbo FU ; Lijun SU ; Mianguang WANG ;
Chinese Traditional Patent Medicine 1992;0(10):-
Objective: To establish the detemination method of bismuth subcarbonate in Weishu Powder. Methods: The samples were ignited, then bismuth subcarbonate in residue was determined by compleximetry. Results: The average recovery was 99.36?0.14%(n=9). Conclusion: This method can be used in quality control of Weishu Powder preparation.
7.Inhibition of miR-9 expression suppresses proliferation, invasion and mi-gration of nasopharyngeal carcinoma cells
Chaopan ZHENG ; Ling HAN ; Weijian HOU ; Yihui WEN ; Ran FU ; Weiping WEN
Chinese Journal of Pathophysiology 2014;33(4):640-644
AIM:To investigate the effects of down-regulated miR-9 expression on the proliferation , invasion and migration of nasopharyngeal carcinoma (NPC) cells.METHODS:Human NPC CNE1 and CNE2 cells were transfect-ed with the inhibitor of miR-9 by Lipofectamine to down-regulate the expression of miR-9, and the cells transfected with an inhibitor control were also set up .The cell proliferation and cell cycle were evaluated by CCK-8 assay and flow cytometry . The cell invasion and migration abilities were detected by Transwell invasion and wound -healing assays .Immunoblotting was applied to analyze the levels of the proteins .RESULTS:Compared with control group , inhibition of miR-9 expression in the NPC cells by transfection of the miR-9 inhibitor significantly decreased the proliferation ability (P<0.05).The per-centages of the cells in G 0/G1 phase [ CNE2: ( 57.96 ±1.39 )% vs ( 47.93 ±1.76 )%, P<0.05; CNE1: ( 51.24 ± 0.88)%vs (48.29 ±0.39)%, P<0.05] were significantly increased.The migration distances [CNE2: (186.50 ± 7.94)μm vs (247.56 ±15.56)μm, P<0.05;CNE1:(139.06 ±16.73)μm vs (230.66 ±14.27)μm, P<0.01] and the invasion ability of the CNE2 cells (43.00 ±3.17 vs 65.80 ±5.20, P<0.01) were also significantly inhibited .Moreo-ver, the tumor cells transfected with the inhibitors produced lower β-catenin.CONCLUSION:Inhibition of miR-9 expres-sion suppresses the proliferation , invasion and migration of nasopharyngeal carcinoma cells .
8.Uncoupling protein 2 variants and cell proliferation and apoptosis of human umbilical vein endothelial cells
Yinchen SHEN ; Feng'e CHEN ; Tao SUN ; Qing GU ; Kun LIU ; Zhi ZHENG ; Yihui CHEN ; Ning WANG ; Xun XU
Chinese Journal of Ocular Fundus Diseases 2017;33(1):52-56
Objective To observe the influences of uncoupling protein 2 (UCP-2) rs660339 variants transfection on cell proliferation and apoptosis of human umbilical vein endothelial cell (HUVEC). Methods Two UCP-2 green fluorescent protein (GFP) lentivirus constructs were created with the rs660339 locus carried C or T (UCP-2C or UCP-2T), respectively. HUVEC were cultured after lentiviral infection of UCP-2C or UCP-2T. The expression of UCP-2C or UCP-2T was detected with real time polymerase chain reaction. Cell proliferation and cell apoptosis were compared among negative control (NC) group, UCP-2T group and UCP-2C group using CCK-8 cell viability and flow cytometry. Western blot and immunostaining were employed to examine the expression of Bcl-2 gene. Results The lentivirus constructs were successfully created.>80%of the transfected cells were found to express GFP under fluorescent microscope. The mRNA levels of UCP-2 gene were significantly increased (F=29.183, P=0.001) in the UCP-2T group and UCP-2C group. The CCK-8 assay revealed that on day two (F=15.970, P=0.004), day three (F=16.738, P=0.004), day four (F=5.414, P=0.045) post-infection, UCP-2T and UCP-2C group showed significantly greater proliferation than the NC cells. The apoptotic rate in the UCP-2T and UCP-2C group was significantly lower than NC group (F=277.138, P=0.000), and the apoptotic rate of UCP-2T was significantly lower than that of UCP-2C (P=0.003). The protein levels of Bcl-2 in the UCP-2T and UCP-2C group were significantly greater than that in the NC group (F=425.679, P=0.000), and the Bcl-2 expression of UCP-2T was greater than that of UCP-2C (P=0.002). The Bcl-2 density in the UCP-2T and UCP-2C group were greater than that in the NC group (F=11.827, P=0.008), while there was no difference between UCP-2T and UCP-2C group (P=0.404). Conclusion The variants of UCP-2 rs660339 may influence HUVEC proliferation and apoptosis, and UCP-2T showed a stronger effect of inhibiting apoptosis than UCP-2C.
9.Relationship of CTLA-4 polymorphisms with susceptibility for idiopathic dilated cardiomyopathy
Ying LIU ; Wei LIU ; Weimin LI ; Yue LI ; Yihui KONG ; Runtao GAN ; Zheng WANG ; Ying FAN ; Jianqiang GENG ; Qun SHAO ; Mei ZHANG ; Cheng GAO ; Xiurong WANG
Chinese Journal of Immunology 1985;0(01):-
Objective:Autoimmune mechanisms, including cellular and humoral immune, are likely to participate in the pathogenesis of at least a subgroup of idiopathic dilated cardiomyopathy(IDC), in which cellular immune-mediated one plays a more important role. Cytotoxic T lymphocyte associated antigen-4(CTLA-4) is the major negative regulatory factor of cellular immunity. This study was conducted to investigate the association of CTLA-4 gene promoter -318C/T polymorphism, exon 1 A/G polymorphism and 3′ untranslated region microsatellite polymorphism with susceptibility to IDC in Han Chinese.Methods:Polymerase chain reaction-restriction fragment length polymorphisms(PCR-RFLP) techniques were used to analyze the polymorphisms of CTLA-4 promoter -318, exon 1 A/G and 3′ untranslated region in the unrelated Han ethnic population in Heilongjiang Province(including 72 IDC patients and 100 normal controls). Serum sCTLA-4 was tested by ELISA. The relationship of CTLA-4 genotype and alleles frequencies with sCTLA-4 was evaluated by linear regression analysis.Results:Compared with controls, the frequencies of GG genotype(0.604 2 and 0.739 6, P=0.012) and the G allele(0.360 0 and 0.560 0, P=0.008) were significantly increased in patients with IDC. Increased serum sCTLA-4 was found in the IDC group compared with the controls[(1.87?1.06)?g/L vs (0.54?0.19)?g/L, P
10.Research progress in high mobility group box-1 in hypoxic-ischemic brain damage
Xiaoli FENG ; Yihui ZHENG ; Zhenlang LIN
Chinese Journal of Perinatal Medicine 2022;25(8):626-630
Inflammation plays an important part in neonatal hypoxic-ischemic brain damage (HIBD). High mobility group box-1 protein (HMGB1), a neuroinflammatory trigger, has a dual effect on HIBD: in the acute stage, it amplifies the ischemic tissue injury; in the later stage, it is involved in the neurovascular repair and reconstruction. The significance of HMGB1 in the pathogenesis of HIBD is still not fully understood. This review summarizes the role of HMGB1 in HIBD, including its effects on neurons, glial cells and blood-brain barrier, and the underlying mechanisms as well as the progress in research on HMGB1 in immature brain, hoping to provide new ideas for neuroprotection in HIBD.